Concomitant surgical ablation or left atrial appendage occlusion at the time of cardiac
surgery should be performed in nearly all patients with atrial fibrillation to improve
long-term outcomes.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Seminars in Thoracic and Cardiovascular SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Does surgical ablation for atrial fibrillation benefit patients undergoing bioprosthetic valve replacement?.Semin Thorac Cardiovasc Surg. 2022; 34: 906-915
- Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery.J Thorac Cardiovasc Surg. 2018; 155: 159-170
- Surgical ablation of atrial fibrillation in hypertrophic obstructive cardiomyopathy: Outcomes of a tailored surgical approach.J Card Surg. 2020; 35: 2957-2964
- How does chronic atrial fibrillation influence mortality in the modern treatment era?.Curr Cardiol Rev. 2015; 11: 190-198
- Left atrial appendage occlusion during cardiac surgery to prevent stroke.N Engl J Med. 2021; 384: 2081-2091
Article info
Publication history
Published online: June 20, 2021
Footnotes
Conflicts of Interest: Dr Hodges is a consultant for AtriCure. Dr Burns is a consultant for Medtronic. Dr Gillinov is a consultant for Edwards, Medtronic, Cryolife, Abbott, ClearFlow, and AtriCure. Dr Suri has no conflicts of interest.
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Does Surgical Ablation of Atrial Fibrillation Benefit Patients Undergoing Bioprosthetic Valve Replacement?Seminars in Thoracic and Cardiovascular SurgeryVol. 34Issue 3
- PreviewThe benefit of avoiding lifelong anticoagulation therapy in patients with bioprosthetic heart valve implantation may potentially be offset by atrial fibrillation (AF); however, clinical impact of surgical AF ablation in such patients remains controversial. We enrolled 426 patients (aged 72.0 ± 7.8 years) with AF who underwent left-side valve replacement with bioprostheses between 2001 and 2018. Of these, 297 underwent concomitant surgical ablation (ablation group) and 129 underwent valve replacement alone (non-ablation group).
- Full-Text
- Preview
